Literature DB >> 20379723

[Current treatment indications and treatment options for retinal astrocytic hamartoma].

S Mennel, S Peter, J C Schmidt, C H Meyer.   

Abstract

Entities:  

Mesh:

Year:  2010        PMID: 20379723     DOI: 10.1007/s00347-010-2156-1

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


× No keyword cloud information.
  8 in total

1.  Photodynamic therapy with Verteporfin for vascular leakage from a combined hamartoma of the retina and retinal pigment epithelium.

Authors:  Helena Cilliers; C Alex Harper
Journal:  Clin Exp Ophthalmol       Date:  2006-03       Impact factor: 4.207

2.  Resolution of exudative retinal detachment from retinal astrocytoma following photodynamic therapy.

Authors:  Carol L Shields; Miguel A Materin; Brian P Marr; Jaime Krepostman; Jerry A Shields
Journal:  Arch Ophthalmol       Date:  2008-02

3.  Autofluorescence and angiographic findings of retinal astrocytic hamartomas in tuberous sclerosis.

Authors:  Stefan Mennel; Carsten H Meyer; Fred Eggarter; Silvia Peter
Journal:  Ophthalmologica       Date:  2005 Nov-Dec       Impact factor: 3.250

4.  Photodynamic therapy for exudative hamartoma in tuberous sclerosis.

Authors:  Stefan Mennel; Norbert Hausmann; Carsten H Meyer; Silvia Peter
Journal:  Arch Ophthalmol       Date:  2006-04

Review 5.  Current treatment modalities for exudative retinal hamartomas secondary to tuberous sclerosis: review of the literature.

Authors:  Stefan Mennel; Carsten H Meyer; Silvia Peter; Jörg C Schmidt; Peter Kroll
Journal:  Acta Ophthalmol Scand       Date:  2007-03

Review 6.  Ocular photodynamic therapy--standard applications and new indications (part 1). Review of the literature and personal experience.

Authors:  Stefan Mennel; Irene Barbazetto; Carsten H Meyer; Silvia Peter; Michael Stur
Journal:  Ophthalmologica       Date:  2007       Impact factor: 3.250

7.  [Clinical course of a solitary retinal astrocytoma].

Authors:  M Töteberg-Harms; F Paulsen; G I W Duncker; S Sel
Journal:  Ophthalmologe       Date:  2009-10       Impact factor: 1.059

8.  Photodynamic therapy with verteporfin to induce regression of aggressive retinal astrocytomas.

Authors:  Sebastian Eskelin; Petri Tommila; Tapani Palosaari; Tero Kivelä
Journal:  Acta Ophthalmol       Date:  2008-08-27       Impact factor: 3.761

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.